- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03374189
Prospective Study on a Novel Port-site Closure Device (EZ Close): Effectiveness and Comparison With Carter-Thomason
February 13, 2019 updated by: Hee Youn Kim, Saint Vincent's Hospital, Korea
Single Blind Randomized Control Trial Evaluating Efficacy and Safety of EZ-Close Port-site Closure Device Versus Carter-Thomason Device
This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Port-site closure is a critical procedure after every laparoscopic surgery.
Complications such as visceral organ injury, port-site hernia, infection, ascitic fluid leakage may occur during and after the procedure.
Many devices were developed and utilized for the procedure and Carter-Thomason is one of the most commonly used device and validated with several studies.
This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.
Study Type
Interventional
Enrollment (Actual)
79
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Suwon, Korea, Republic of, 16247
- St. Vincent's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients with laparoscopic ports over 10mm
Exclusion Criteria:
- Patients with laparoscopic ports under 10mm
- Patients who refused the study
- Patients who received concurrent surgery for other reason
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: EZ Close arm
EZ close used for port-site closure.
|
EZ close used.
|
ACTIVE_COMPARATOR: Carter Thomason arm
Carter Thomason used for port-site closure.
|
Carter Thomason used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time Taken to Complete Closure
Time Frame: At the time of surgery
|
The start of the procedure was defined as the point when the device was first inserted through the port-site and the end of the procedure was defined as the point when the port-site was removed from the port-site.
A stopwatch was used to measure the time.
|
At the time of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Visceral Organ Injury
Time Frame: At the time of surgery
|
Any inadvertent injury to organs or bleeding during procedure.
|
At the time of surgery
|
Number of Participants With Need for Additional Instrument
Time Frame: At the time of surgery
|
Need for additional instrument during procedure
|
At the time of surgery
|
Number of Participants With Port-site Hernia
Time Frame: 3 days post-op and within one months of surgery
|
Herniation of bowel segments through port-site
|
3 days post-op and within one months of surgery
|
Number of Participants With Port-site Infection
Time Frame: 3 days post-op and within one months of surgery
|
Redness, purulent discharge, tenderness at port-site
|
3 days post-op and within one months of surgery
|
Number of Participants With Ascitic Fluid Leakage
Time Frame: 3 days post-op and within one months of surgery
|
Non-infective fluid leakage
|
3 days post-op and within one months of surgery
|
Number of Participants With Wound Dehiscence
Time Frame: 3 days post-op and within one months of surgery
|
Wound dehiscence that required further treatment
|
3 days post-op and within one months of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hee Youn Kim, St Vincent's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- del Junco M, Okhunov Z, Juncal S, Yoon R, Landman J. Evaluation of a novel trocar-site closure and comparison with a standard Carter-Thomason closure device. J Endourol. 2014 Jul;28(7):814-8. doi: 10.1089/end.2014.0069. Epub 2014 Apr 23.
- Shetty A, Adiyat KT. Comparison between hand suture and Carter-Thomason needle closure of port sites in laparoscopy. Urol J. 2014 Sep 2;11(4):1768-71.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 17, 2017
Primary Completion (ACTUAL)
May 9, 2018
Study Completion (ACTUAL)
May 24, 2018
Study Registration Dates
First Submitted
December 11, 2017
First Submitted That Met QC Criteria
December 11, 2017
First Posted (ACTUAL)
December 15, 2017
Study Record Updates
Last Update Posted (ACTUAL)
March 1, 2019
Last Update Submitted That Met QC Criteria
February 13, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EZVSCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Port Site Hernia
-
The University of Texas Health Science Center,...NeoSurgical LimitedCompleted
-
Hospital General Universitario ElcheCompleted
-
Central Hospital, Nancy, FranceUnknownSurgical Site InfectionFrance
-
Istanbul University - Cerrahpasa (IUC)RecruitingVentral Hernia | Surgical Site InfectionTurkey
-
Bengt NovikUppsala University; Swedish Hernia Registry; Skaraborg Hospital Research & Development...CompletedRecurrence | Hernia | Hernia, Inguinal | Laparoscopy | Hernia, Femoral | Surgical Mesh | Fixation Device; Complications | Surgical Procedures, Minimally Invasive | Surgical Staplers
-
Hospital de GranollersRecruitingHernia, Abdominal | Surgery--Complications | Surgical Site Infection | Colorectal Surgery | Cesarean Section; InfectionSpain
-
Assiut UniversityNot yet recruitingPostoperative Pain | Surgical Site Infection | Incisional Hernia
-
Kristian Kiim JensenNot yet recruitingQuality of Life | Surgical Wound Infection | Surgical Site Infection | Incisional HerniaDenmark
-
Hospital de GranollersCompleted
-
University Hospital, Basel, SwitzerlandSt. Claraspital AG; Clarunis - Universitäres Bauchzentrum BaselRecruitingHernia, Inguinal | Robotic Surgical ProceduresSwitzerland
Clinical Trials on EZ close
-
WellSpan HealthUniversity of PennsylvaniaCompletedDifficult Peripheral IV AccessUnited States
-
Vidacare CorporationCompletedPatients Requiring Urgent Vascular AccessUnited States
-
MIVI Neuroscience, Inc.Not yet recruitingAcute Ischemic Stroke
-
Vidacare CorporationCompleted
-
Cornell UniversityRecruitingPain ThresholdUnited States
-
AZ Sint-Jan AVCompletedAtrial FibrillationBelgium
-
Stanford UniversitySurgSolutions, LLCCompleted
-
University of California, San DiegoCalifornia Department of Public Health; Community Beyond Violence; Sierra Community... and other collaboratorsEnrolling by invitationSexual Violence | Adolescent Behavior | Sexual AssaultUnited States
-
Groupe Hospitalier de la Rochelle Ré AunisCompleted
-
Vidacare CorporationCompletedIntraosseous Vascular AccessUnited States